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Background: Florfenicol, a commonly used veterinary antibiotic, was reported to have caused a severe drop in egg
hatchability following its off-label use on a broiler breeder farm in South Africa. According to the pharmacovigilance
report, hatchability dropped by 80 % for up to a week following a five day course at 10 mg/kg (both males and
females treated metaphylactically) to manage an Escherichia coli infection. While mammalian toxicity studies indicate
the potential for early embryonic death in utero or testicular damage, no literature is available on the avian toxicity of
florfenicol. For this study we investigated the effects of florfenicol at various doses from 10 to 90 mg/kg on the egg
hatchability in a breeder flock we kept and established under controlled conditions, with the same cockerels and
hens being exposed in a phased manner.
Results: Following five days of oral exposure, no toxic signs were evident in any of the cockerels or hens treated at
doses up to 90 mg/kg. Treatment of only the cockerels had no effect on egg hatchability, while treatment of only
the hens at doses of 60 and 90 mg/kg resulted in decreased hatchability of 0 % in comparison to 70 % of the control
as early 24 h after treatment. In all cases, decreased hatchability was associated with embryonic death at 5 days of
development. The toxic effects of florfenicol were completely reversible with comparable hatchability being present
by day 4 post-treatment withdrawal. Toxicity correlated with total egg florfenicol concentrations with an LC50 of
1.07 μg/g.
Conclusion: Florfenicol appears to be toxic to the developing chick embryo at around day 5 of incubation, in the
absence of related toxicity in the hen or cockerel.
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A spontaneous adverse reaction was reported to the
Faculty of Veterinary Science, University of Pretoria,
South Africa (reporter’s details are kept confidential),
describing an outbreak of Escherichia coli induced mor-
talities in a grandparent layer breeder flock in South
Africa following the use of florfenicol. The report was
according to South African legislation which supports
the reporting of adverse reactions even when the arising
through the use of non-registered and compounded
medicines [1]. According to the spontaneous report,
sensitivity testing showed florfenicol as the only drug
with good efficacy. Florfenicol is a fluorinated derivative
of cloramphenicol [2], with the chemical name 2,2-* Correspondence: vinny.naidoo@up.ac.za
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stated.dichloro-N-[1-(fluoromethyl)-2-hydroxy-2-[(methylsulfo-
nyl) phenyl] ethyl] acetamide within the amphenicol
group of antibiotics, with wide scale use in the treatment
of pneumonia in food-producing animals [3]. In contrast
to chloramphenicol which has been associated with the
occurrence of aplastic anaemia in people, florfenicol does
not contain the nitro group making it safe for use in
food-producing animals [4]. Florfenicol is primarily bac-
teriostatic, with a range of activity against many Gram-
negative and Gram-positive organisms, including certain
chloramphenicol-resistant strains of Escherichia coli,
Salmonella typhimurium and Staphylococcus aureus [5].
Florfenicol functions through the suppression of protein
synthesis by inhibiting the peptidyl transferase enzyme as
well as ribosomal translocation [6, 7].
While not registered for use in breeder fowls, the
treating veterinarian made an informed decision to treat
the birds with the non-registered florfenicol. The birdsss This article is distributed under the terms of the Creative Commons
ativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution,
u give appropriate credit to the original author(s) and the source, provide a link
e if changes were made. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Table 1 Percentage fertility recorded during the study when
only the hens were treated at the 10, 20 or 30 mg/kg (n = 30)
and the method of evaluation
Time Event Dose administered (mg/kg) Method
0 10 20 30
−24 Day before treatment 88 93 87 77 Hatch
24 24 h after 1’st Treatment 89 78 76 76 Break-out
72 24 h after third treatment 74 70 73 61 Hatch
96 24 h after 4’th treatment 86 90 73 74 Break-out
120 Day 1 after withdrawal 94 85 79 85 Break-out
168 Day 3 after withdrawal 75 73 66 78 Hatch
192 Day 4 after withdrawal 81 82 70 89 Break-out
240 Day 6 after withdrawal 83 82 90 87 Break-out
264 Day 7 after withdrawal 77 77 89 78 Hatch
Time- indicates the time of eggs collection in relation to treatment. Method-
indicates the methodology used to ascertain fertility for the specified time
point. Values are presented as the percentage fertility of the total number of
eggs incubated
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col formulation (active in glycerol), produced by a local
pharmacy (Vtech compounding solutions), in the water
at an equivalent dose of 10 mg/kg for 5 days. According
to the spontaneous report the hens made a complete
recovery with no further mortalities being recorded. A
major side effect of reduced hatchability of 80 % was
reported, which lasted for a week from treatment ini-
tiation before returning to normal. Despite numerous
attempts, further information was not forthcoming from
the veterinarian or the farm in question.
While florfenicol is a described reproductive toxin this
information has largely been obtained from classical mam-
malian laboratory toxicity tests. According to the summary
material safety data sheet published by Schering-Plough
[8], an oral two-generation reproductive study in rats
(12 mg/kg/day for 90 days) revealed reduced epididymal
weights, decreased pup survival, and reduced milk pro-
duction. Another two-generational teratogenicity study in
mice, florfenicol (40, 120, or 400 mg/kg by gavage) on
days 6-15 of gestation showed signs of embryo lethality at
the high dose. With an extensive literature review yielding
no further information on the in vivo avian toxic potential
of florfenicol, the aim of the following study was to estab-
lish the toxic effects of florfenicol on egg hatchability in a




Hyline hens were purchased from Eggspert eggs (Kempton
Park, South Africa) and cockerels from HyLine SA
(Midrand-South Africa) at the age of 15 weeks and already
vaccinated for local conditions. The birds were individually
marked with patagial tags prior to being randomly divided
into four groups of 30 hens and 4 cockerels. The hen
to cockerel ratio was at the recommended ratio of 8:1
for highest fertility within breeder flocks [9]. Birds were
housed in large open pens of which the floors were cov-
ered with wood shavings in naturally ventilated rooms
with curtained windows and had access to a standard diet
fortified with salinomycin at 50 ppm (Avi-Products Pty)
and potable municipal water ad libitum. Research was
approved by the Animal Use and Care Committee of the
University of Pretoria (V070-08) and was conducted
according the South Africa standards for the use of
animals in research.
Experimental design
Florfenicol was supplied by Vtech Compounding Solu-
tions Pharmacy (Midrand, South Africa) as the exact
formulation (florfenicol in glycerol to a final concentration
of 30 mg/ml) reported in the spontaneous report. The
study was completed in three phases with the same groupof birds being used in all phases and a wash-out
period of 3 weeks between phases. Treatments were
administered once daily for 5 days by direct adminis-
tration into the crop to ensure the correct exposure. In
phase 1, only the hens were treated at concentrations of
10, 20 and 30 mg/kg or sterile water. In phase 2, only the
cockerels were treated with florfenicol at 30, 60, and
90 mg/kg or sterile water (Higher doses were selected
due to the absence of toxicity in phase 1). In phase 3,
only the hens were treated with florfenicol at 30, 60 and
90 mg/kg or sterile water. Prior to each phase the birds
were all deemed to be clinically healthy, within normal
weight limits, with all treatment groups having equivalent
or better egg hatchability to the control.
Monitoring of birds and chicks
Hens and cockerels were evaluated daily for clinical
signs of toxicity. Eggs were also collected on selected
days for incubation (Buckeye egg incubator at 37 to
37.5 °C at 50 % relative humidity, automatically turned
hourly) to determine fertility by candling, egg break-outs
or hatchings. A staggered pattern was adopted due to
limited incubator space (Table 1). In total 30 eggs were
incubated per time point for phase 1 and 2 and the
majority of phase 3 (Tables 1, 2, 3). Fewer eggs were
available for incubation in phase 3 due to a sequential
termination of the adult hens for necropsy evaluation.
Final egg evaluations by candling was undertaken on day
18. Eggs deemed infertile on candling were subjected to
break-outs to determine time of embryonic death accord-
ing to standard charts [10], while fertile eggs were taken
to hatch. Fertility from the break-outs is presented as the
percentage of eggs with viable foetuses (% fertility). For
eggs taken to hatch, chicks were evaluated for their
Table 2 Percentage fertility recorded during the study when
only the cockerels were treated at the 30, 60 or 90 mg/kg
(n = 30) and the method of evaluation
Time Event Dose administered (mg/kg) Method
0 30 60 90
−24 Day before treatment 81 72 71 67 Hatch
24 24 h after 1’st Treatment 92 92 88 92 Break-out
72 24 h after third treatment 75 92 73 76 Hatch
96 24 h after 4’th treatment 87 86 83 77 Break-out
120 Day 1 after withdrawal 70 77 83 83 Break-out
168 Day 3 after withdrawal 70 65 62 77 Hatch
192 Day 4 after withdrawal 87 92 87 87 Break-out
240 Day 6 after withdrawal 86 90 93 92 Break-out
264 Day 7 after withdrawal 63 77 63 57 Hatch
Time- indicates the time of eggs collection in relation to treatment. Method-
indicates the methodology used to ascertain fertility for the specified time
point. Values are presented as the percentage fertility of the total number of
eggs incubated
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shape of their beaks, movement ability and presence or
absence of open navels. At the end of phase 3, hens in
groups of five were sacrificed using CO2 at 0, 1, 2, 3
and 4 days post drug withdrawal for general necropsy
evaluation.Florfenicol quantification in the egg
In phase 3, eggs collected on days 1 to 5 after treatment
withdrawal were randomly collected from each group for
quantification of their florfenicol concentrations using a
modified method of Varma [3]. Eggs were cracked, shellsTable 3 Percentage fertility recorded during the study when
only the hens were treated at the 30, 60 or 90 mg/kg and the
method of evaluation
Time Event n Dose administered
(mg/kg)
Method
0 30 60 90
−24 Day before treatment 30 70 77 90 73 Hatch
24 24 h after 1’st Treatment 30 70 69 3 0 Break-out
72 24 h after third treatment 30 50 52 0 0 Hatch
96 24 h after 4’th treatment 30 71 81 0 0 Break-out
120 Day 1 after withdrawal 25 71 64 12 8 Break-out
168 Day 3 after withdrawal 15 66 71 0 0 Hatch
192 Day 4 after withdrawal 10 80 100 60 75 Break-out
240 Day 6 after withdrawal 5 80 100 60 75 Break-out
264 Day 7 after withdrawal 5 80 100 67 100 Hatch
Time- indicates the time of eggs collection in relation to treatment. Method-
indicates the methodology used to ascertain fertility for the specified time
point. Values are presented as the percentage fertility of the total number of
eggs incubated. From 120 h, five hens per days were slaughtered for necropsy
evaluationdiscarded and the yolk/albumin homogenised. Two grams
of egg homogenate in natural proportions were mixed
with 100 μl of 10 μg/ml thiamphenicol (internal standard)
and 9 ml ethyl acetate, vortexed and subsequently centri-
fuged at 2000 × g for 15 min. The resulting supernatant
was decanted into a new tube, dried off for 30 min at
60 °C under a stream of nitrogen, prior to being mixed
with 2 ml high pure water (MilliQ) and 2 ml hexane and
re-centrifuged at 2000 × g for 15 min. For final extraction
the supernatant was subjected to solid phase extraction
(Varian BondElut C18) on cartridges primed with 4 ml
methanol, followed by 4 ml MilliQ50 water. After the
sample loading, a second wash was performed using 2 ml
MilliQ50 water after which the cartridge was allowed to
dry under vacuum for 5 min. Final elution was with 3 ml
methanol under vacuum for 5 min. The eluent was dried
under a stream of nitrogen for 30 min at 60 °C, prior to
being reconstituted in 500ul of 30 % acetonitrile in
reverse osmosis water (mobile phase) of which 100 μl
was injected onto the column [Phenomenex guard
cartridges (AJO-4287) and LG reverse phase, Luna
5μaC18 (2); 100A; 150 × 4.6 mm] under isocratic flow
of 1 ml/min. Detection was via diode array on a Beckman
HPLC at 223 nm (Fig. 1).
Results were interpreted against a fortified curve in
which known concentrations of florfenicol and thiam-
phenicol were added to eggs collected from the control
birds for which were maintained strictly florfenicol free
for the entire study (Fig. 2). The method was linear from
0.1 to 10 μg/g, with 0.1 μg/ml being the visual limit of
the detection. The intra-day recovery (n = 2) was 91.96
and 103.02 % for the lowest and highest concentration
with a corresponding relative standard deviation (RSD)
of 3.8 and 1.21 % respectively. The inter-day recovery
(n = 5) was 103.71 and 104.81 % for the lowest and
highest concentration, with the corresponding RSD being
9.23 and 5.56 % respectively. All analysis was undertaken
over a period of 5 days.
Florfenicol concentrations are presented for the dif-
ferent dose groups as mean and standard deviation. Egg
concentrations were compared to the corresponding per-
centage fertility obtained by egg break-out. The florfenicol
concentrations were plotted against percentage fertility on
the natural logarithm scale to ascertain if a linear concen-
tration versus response was present. The estimated con-
centration which could induce a 50 % reduction in fertility
(LC50 %) was calculated from the best fit equation ob-
tained by linear regression.
Results
For this study we investigated a pharmacovigilance report
suggesting the reproductive toxic effect of florfenicol in a
commercial breeding chicken flock. To obtain realistic
results, we established breeding flocks with a hen to
Fig. 1 Chromatogram for the 10 μg/ml sample, with the thiamphenicol internal standard
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ascertain whether the effect was on the hens in the
flocks, the cockerels in the flocks or just on eggs, the
study was divided into three phases. For all three phase
the same breeding birds were used. No clinical signs of
toxicity were evident in any bird during the study.
The fertility of the flock was generally excellent and was
above 70 % at the start of each phase as determined by
break-outs, and was comparable to the industry standard
[11] with hatchability decreasing, as expected with the
flock aging. Fertility as measured by hatchings were not
as favourable as for the break-outs on certain days. How-
ever, since the fluctuations are a natural occurrence, the
results for the treatment groups were always compared to
the control group to rule out incidental environmental
influences on hatchability.Fig. 2 Fortified standard curve for the various concentrations of florfenicolIn phase 1 (low dose hen) the only abnormality was
a mild drop in fertility immediately after the fourth
treatment of 72 and 74 % for the 20 and 30 mg/kg groups
respectively in comparison to 93 % for the control group
on break-outs (Table 1). This decrease corresponded with
similar decrease in chicks hatching. No other time points
in phase 1 showed signs of toxicity. In phase 2 (high dose
males), no changes in fertility were observed for any of the
groups (n = 30) with all groups showing similar % fertility
to the control group (Table 2). No abnormalities were
seen in any of the hatched chicks in phase 1 and 2.
In phase 3, evidence of decreased fertility was present
in both the 60 and 90 mg/kg groups (Table 3), with the
day 18 percentage fertility being 3 and 0 % respectively
as early as 24 h after the first dose (n = 30). In contrast
the control group had a percentage fertility of 70 %.spiked into egg samples
AL-Shahrani and Naidoo BMC Veterinary Research  (2015) 11:213 Page 5 of 7Fertility remained low until day 4 after treatment cessation
(n = 5), with no chicks hatching from these treatment
groups. Hereafter hatchability returned to control levels
with no signs of abnormalities being present in hatching
chicks. While none of the hens showed any signs of abnor-
malities on necropsy, egg breakouts showed that foetal
deaths resulted at approximately day 5 of development.
Post-treatment egg concentration for the 90 mg/kg
group was 4.27 ± 0.76 μg/g on day 1 and had declined
to 0.85 ± 0.05 μg/g by day 5 post-0 mg/kg treatment
(Table 4). The depletion was not linear for all the groups
with the 30 and 60 mg/kg group showing an increase in
concentration from 24 to 48 h, before starting to decline.
When the percentage fertility was plotted against florfeni-
col egg concentrations, a linear relationship was present
with linearity of >85 % (Fig. 3). The best fit equation was
defined as y =-0.65× + 4.61, and an LC50 of 1.07 μg/g.
Discussion
This is the first report of an adverse reaction associated
with the use of florfenicol in breeding poultry that we
are aware of, even though formulations of florfenicol are
available for use in broilers internationally. For this
study, we exposed an established breeder flock to florfe-
nicol in controlled manner to ascertain if the drug could
interfere with fertility as well as to determine if toxicity
was at the level of the cockerel, hen and/or embryo. The
reason for adopting this specific design came from the
non-specific information provided in the spontaneous
adverse drug report that related treatment to a subse-
quent decrease in fertility in a breeder flock. With the
treatment being administered in the water and subse-
quent non-specific exposure of both the cockerels and
hens, the resultant toxicity could have been from a
direct toxic effect in either the cockerel or hen by inter-
fering with their breeding potential. It is also possible
that due to the drug’s lipid solubility, it was distributed
into either the albumin or yolk and subsequently was
toxic to only the developing embryo.
In general florfenicol was not characterised by any overt
signs of toxicity or pathological changes in the treated birds.
For phase 1, in which the hens were treated at lower dosesTable 4 Concentration (μg/g) of florfenicol in the eggs (n = 5)
at 24, 48, 72, 96 and 120 h after the withdrawal of treatment of
florfenicol at 30, 60 or 90 mg/kg oid for 5 days
Time after dosing (hour) Dose
30 mg/kg 60 mg/kg 90 mg/kg
24 0.68 ± 0.05 2.2 ± 0.30 4.27 ± 0.76
48 1.08 ± 0.11 2.53 ± 0.24 3.8 ± 0.34
72 0.59 ± 0.02 1.8 ± 0.15 1.85 ± 0.28
96 0.39 ± 0.06 0.6 ± 0.04 1.12 ± 0.13
120 0.27 ± 0.01 0.59 ± 0.13 0.85 ± 0.05of 10, 20 and 30 mg/kg a moderate negative effect on fertil-
ity was seen at 20 and 30 mg/kg after four days of consecu-
tive therapy. On egg break-out this was characterised by
early embryonic death at approximately day 5 of develop-
ment. When only the cockerels were treated in phase 2, no
changes in fertility were evident. For phase 3, in which the
hens were treated at the higher doses of 30, 60 and 90 mg/
kg a major, albeit temporary, decrease in fertility charac-
terised as a 100 % decline was evident. As for phase 1, egg
break-outs indicated that embryonic mortalities occurred at
approximately day 5 of development with good correlation
to total egg florfenicol concentrations.
With the absence of overt toxicity in either hens or
cockerels, the failure of the product to interfere with
cockerel fertility, and the presence of early embryonic
death at day 5, it would appear that florfenicol toxicity is
limited to the developing embryo as a result of depos-
ition of florfenicol within the egg prior to lay. The effect
also appears to be absolute, as in the event that the em-
bryo did not die, normal development to hatch resulted.
The concentration response relationship in toxicity also
provides a plausible link that the florfenicol was the
cause of the embryonic death. This finding does differ to
an in vitro toxicity study undertaken through the injec-
tion of florfenicol at 20 to 30 mg/kg egg weight, into day
4 embryonated eggs from Marandi breed chickens [12].
For the latter study no signs of toxicity was evident at
necropsy on 18 day old embryos. While we are uncertain
for the difference in sensitivity, breed differences may play
a role. Another plausible reason could be the time of ex-
posure, as in vivo exposure would result in the zygote be-
ing exposed to drug from the point of lay, while the older
embryo may have reached a stage of non-susceptibility. As
evident in this study, embryos that do survive florfenicol
exposure do develop into normal healthy chicks.
What was also evident in the study was the slight
difference in the time to maximum concentration
(Cmax) within the eggs, with the 90 mg/kg group reach-
ing Cmax at 24 h post-drug withdrawal and the 30 and
60 mg/kg dose reaching Cmax at 48 h. This would sug-
gest that the deposition of florfenicol into the egg is
highly variable. This finding is not unusual and can be
explained by pharmacokinetic theory which generally
describes the deposition of drugs into the egg as being
highly individually variable. The reasons for the latter is
the need for the drug to distribute into the two media of
the egg, namely the albumin and the yolk [13, 14], with the
distribution being more rapid into the albumin reaching
steady state usually by day 2-3 post-treatment, while steady
state in the yolk can take up to 8 days. In the context of this
study, the highly variable Cmax evident is explainable by
both the variable nature of egg disposition as well as the
study design which relied on eggs being randomly sampled
per time point. Unfortunately in a natural open breeding
Fig. 3 Percentage fertility on the natural logarithmic scale obtained from egg break-out from the batch of eggs incubated (Table 3) versus
corresponding egg florfenicol concentration (n = 5) from the separate batch of eggs assayed by HPLC
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open floors, it is not possible to sequentially collect eggs
from the same hen as their eggs are not identifiable.
Despite some previous evidence of embryotoxicity in
the mouse, the mechanism of toxicity of florfenicol is yet
to be described. Literature is however available for the
other molecules in the amphenicol class. In a controlled
murine study, 14- or 20-somite embryonic stages ex-
posed to chloramphenicol (the progenitor compound of
the amphenicol group), at concentrations of 0, 200, or
300 μg/ml for 22 – 24 h showed defects of the neural
tube (failure to close) and the forebrain as well as the
inhibition of haemoglobin formation [15]. The study was
able to demonstrate that the toxic effect was due to
inhibition of protein synthesis as a result of interference
with the messenger RNA. In another study, chloram-
phenicol injected into turkey hatching eggs to eliminate
Mycoplasma meleagridis at doses of 2.5 and 5 mg also
reduced hatchability, with embryo deaths being recorded
before day 9 of the incubation period [16]. Finally in a
rat model of teratogenicity it was found that the chloram-
phenicol interfered specifically with mitochondrial protein
synthesis by decreasing the production of mitochondrial
cytochrome oxidase enzyme (Cytochrome C oxidase is
the terminal enzyme in the electron transport chain
located on the inner mitochondrial membrane) [17]. With
florfenicol and chloramphenicol both sharing the same
mechanism of protein synthesis inhibition, it is likely that
florfenicol is toxic to the early stages of embryonic devel-
opment via foetal protein synthesis inhibition.
Another important finding in this study was the lower
susceptible of the study bird than that reported for the
adverse drug reaction. While the reason for this differ-
ence is not known, it is possible that housing conditions,
total days in lay, and the presence of the E. coliinfections add to the general toxicity of the molecule.
While it may be argued that the doses in use were exces-
sively high and therefore unlikely to represent field ad-
verse drug reactions, this is unlikely as the model is
based on current regulatory best practice in evaluating
drug toxicities. In the standard development of a veterin-
ary medicine, it is a requirement for the drug to be tested
at a control overdose (target species toxicity) at a minimum
of 3x and 5x an overdose, with 10x overdose being the
upper end of the scale [18]. The aim of these target species
toxicity studies is to elucidate the toxic potential of a mo-
lecular in the target species as well to describe its likely ad-
verse reaction from use i.e. these studies use a higher dose
to elucidate likely side effects in a small sample size. For
this study, birds exposed to a 3x to 9x overdose all showed
signs of embryonic toxicity making it likely that this side ef-
fect would result under field conditions. Also important to
note is that the non-South African recommended dose for
the treatment of broiler chickens is 30 mg/kg, the lowest
identified toxic dose for this study [19].
An unexpected finding of this study was the absence
of decreased egg fertility when only the cockerels were
treated, as previous mammalian have indicated the abil-
ity for the drug to induce testicular toxicity. From Ando
et al testicular toxicity seen in rats was characterized
by vacuolated Sertoli cells was most likely as a result of
reduced cytochrome activity [20]. With the cytochrome
oxidases being important for aerobic sperm production,
it would appear that avian Sertoli cells are less sensitive
to the effects of the amphenicols. This also highlights
that mammalian toxicity studies are not necessary indi-
cative of toxicity in avian species. However, it must be
noted that this study was designed to investigate the ef-
fects of florfenicol on cockerel breeding potential under
commercial conditions at a ratio one cockerel to eight
AL-Shahrani and Naidoo BMC Veterinary Research  (2015) 11:213 Page 7 of 7hens, with the result that this study design may not have
been sensitive enough to elucidate more insidious tes-
ticular/epididymal toxicity. As a result, it would still be
important to evaluate the direct effect of florfenicol in a
larger group of breeding-aged cockerels, for further
sex-related side effects.
Conclusion
We conclude that florfenicol has the potential to induce
early embryonal death in chickens. We would recom-
mend that the drug be avoided in breeding birds, unless
the value of the breeder flock dictates that the health of
the flock and return to productivity is more important
than resultant decrease in egg fertility.
Competing interests
None of the authors has any financial or personal relationships that could
inappropriately influence or bias the content of the paper.
Authors’ contribution
VN: Conceptualised the study, assisted with the animal phases, participated
in drafting the manuscript, and served as degree supervisor for SA; SA:
Undertook the research, assisted with the egg analysis, and participated in
drafting the manuscript. Both authors read and approved the final
manuscript.
Acknowledgements
The authors wish to thank Mrs. MSG Mulders who undertook the HPLC
analysis for this project. This project was funded by the Saudi Food and
Drug Authority as part of an MSc student project.
Received: 24 February 2015 Accepted: 6 August 2015
References
1. Naidoo V, Gehring R. Overview of suspected adverse reactions to veterinary
medicinal products reported in South Africa (March 2001-February 2002).
J S Afr Vet Assoc. 2002;73:227–9.
2. Budavari S. The Merck Index. An Encyclopaedia of Chemicals, Drugs, and
Biologicals. 12th ed. New Jersey: Merck Research Laboratories; 1996. p. 41–6.
3. Varma KJ. Microbiology, pharmacokinetic disposition and safety of
florfenicol in cattle. In: Proceedings of the XVIII World Buiatrics Congress.
Italy: Bologna; 1994. p. 18–24.
4. Yunis AA. Chloramphenicol: relation of structure to activity and toxicity.
Annu Rev Pharmacol Toxicol. 1988;28:83–100.
5. Syriopoulou VP, Harding AL, Goldmann DA, Smith AL. In vitro antibacterial
activity of fluorinated analogs of chloramphenicol and thiamphenicol.
Antimicrob Agents Chemother. 1981;19:294–7.
6. Sams RA. Florfenicol: chemistry and metabolism of a novel broad-spectrum
antibiotic. In: Proceedings of the XVIII World Buiatrics Congress. Italy:
Bologna; 1994. p. 13–7.
7. Cannon M, Harford S, Davies J. A comparative study on the inhibitory
actions of chloramphenicol, thiamphenicol and some fluorinated
derivatives. J Antimicrob Chemother. 1990;26:307–17.
8. Schering-Plough. Material Safety Data Sheet, Florfenicol Powders. 2004.
http://www.fws.gov/fisheries/aadap/03_Florfenicol/06_MSDSs/MSDS%2010-
697_Florfenicol.pdf. Accessed Jan 2015.
9. Al-Rawi B. Sex ratio effects on egg production. Poult Sci. 1980;59:1546–7.
10. Hyline: Technical Library - Weekly Performance Standards. 2012.
http://www.hyline.com/userdocs/pages/PERF_STDS_2-12-15.pdf.
Accessed May 2015.
11. Embryonic development of young chicks. 2007. http://www.strombergschickens.
com/fullsize/895/88. Accessed Jan 2014.
12. Tavakkoli H, Derakhshanfar A, Noori GS. The effect of florfenicol egg-
injection on embryonated chicken egg. IJABBR. 2014;2:496–503.
13. Kan CA, Petz M. Residues of veterinary drugs in eggs and their distribution
between yolk and white. J Agric Food Chem. 2000;48:6397–403.14. Hekman P, Schefferlie GJ. Kinetic modelling and residue depletion of drugs
in eggs. Br Poult Sci. 2011;52:376–80.
15. Billett FS, Collini R, Hamilton L. The effects of D- and L-threo-chloramphenicol
on the early development of the chick embryo. J Embryol Exp Morphol.
1965;13:341–56.
16. McCapes R, Yamamoto R, Ortmayer H, Scott W. Injecting antibiotics into
turkey hatching eggs to eliminate Mycoplasma meleagridis infection. Avian
Dis. 1975;19:506–14.
17. Bass L, Liebert CA, Lee MD, Summers AO, White DG, Thayer SG, et al.
Incidence and characterization of integrons, genetic elements mediating
multiple-drug resistance, in avian Escherichia coli. Antimicrob Agents
Chemother. 1999;43:2925–9.
18. VICH. Target Animal Safety for Veterinary Pharmaceutical Products. 2008.
http://www.vichsec.org/component/attachments/attachments/
310.html?task=download. Accessed May 2015.
19. Khalil S, Hamed E, Hassanin O. Residue withdrawal of florfenicol from the
serum and edible tissues of broiler chickens. J Am Sci. 2012;8:514–24.
20. Ando J, Ishihara R, Imai S, Takano S, Kitamura T, Takahashi M, et al.
Thirteen-week subchronic toxicity study of thiamphenicol in F344 rats.
Toxicol Lett. 1997;91:137–46.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
